Negative news coverage of statins may lead people to stop taking their medication; second patient dies in Zafgen obesity drug trial; Gilead defends pricing
Five things for pharma marketers to know: Tuesday, June 9
Study shows Merck’s Januvia does not increase heart risks; a former Genentech exec launches a behavioral health business; lawmakers want black-box warnings on more opioids
For all the scientific tools that have fallen into our hands in the past few years, we are still largely falling short in our efforts to influence our audiences’ behaviors.
The New Holistic Approach to Leveraging a Multi-Channel Contact Center
Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.
AI Deciphered: Discovering the Potential for Marketers and Communicators